This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

IBM's play for HashiCorp raises antitrust concerns in Australia

( January 21, 2025, 01:27 GMT | Official Statement) -- MLex Summary: Global tech company IBM’s bid to acquire cloud-software maker HashiCorp through a share sale agreement has raised antitrust concerns for the Australian competition regulator. In a market inquiries letter published today, the Australian Competition & Consumer Commission said that both IBM and HashiCorp offer various software solutions and related services on a global basis including in Australia. According to the regulator, the two companies actively supply information technology infrastructure-automation software as well as security software through their products. The regulator is seeking feedback until Feb. 4. on whether IBM and HashiCorp compete closely and whether the proposed merger would enable the combined entity to foreclose competitors.The market inquiries letter published by the Australian Competition & Consumer Commission is attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents